好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Joint Commission Primary Stroke Center Certification Increases rt-PA Treatment
Cerebrovascular Disease and Interventional Neurology
(-)
004
Authors/Disclosures
Michael T. Mullen, MD (Temple University) Dr. Mullen has received publishing royalties from a publication relating to health care.
Scott E. Kasner, MD, FAAN (University of Pennsylvania) Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore.
No disclosure on file
Dawn O. Kleindorfer, MD, FAAN (University of Michigan Department of Neurology) Dr. Kleindorfer has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH (FDA) Dr. Albright has nothing to disclose.
No disclosure on file
No disclosure on file
Jack J. Lin, MD (UC Irvine Medical Center) Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.